- Home
- CNNE vs BLFS Comparison
CNNE vs BLFS Comparison
Compare CNNE & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNNE
- BLFS
- Stock Information
- Founded
- CNNE 2014
- BLFS 1987
- Country
- CNNE United States
- BLFS United States
- Employees
- CNNE N/A
- BLFS N/A
- Industry
- CNNE Restaurants
- BLFS Medical/Dental Instruments
- Sector
- CNNE Consumer Discretionary
- BLFS Health Care
- Exchange
- CNNE Nasdaq
- BLFS Nasdaq
- Market Cap
- CNNE 1.1B
- BLFS 1.2B
- IPO Year
- CNNE N/A
- BLFS 1989
- Fundamental
- Price
- CNNE $19.48
- BLFS $25.59
- Analyst Decision
- CNNE Buy
- BLFS Strong Buy
- Analyst Count
- CNNE 3
- BLFS 7
- Target Price
- CNNE $23.33
- BLFS $30.86
- AVG Volume (30 Days)
- CNNE 662.7K
- BLFS 423.5K
- Earning Date
- CNNE 11-11-2025
- BLFS 11-11-2025
- Dividend Yield
- CNNE 3.08%
- BLFS N/A
- EPS Growth
- CNNE N/A
- BLFS N/A
- EPS
- CNNE N/A
- BLFS N/A
- Revenue
- CNNE $437,200,000.00
- BLFS $93,468,000.00
- Revenue This Year
- CNNE N/A
- BLFS $26.07
- Revenue Next Year
- CNNE N/A
- BLFS $16.86
- P/E Ratio
- CNNE N/A
- BLFS N/A
- Revenue Growth
- CNNE N/A
- BLFS 68.16
- 52 Week Low
- CNNE $15.92
- BLFS $19.10
- 52 Week High
- CNNE $22.36
- BLFS $29.55
- Technical
- Relative Strength Index (RSI)
- CNNE 56.46
- BLFS 54.16
- Support Level
- CNNE $18.85
- BLFS $25.17
- Resistance Level
- CNNE $19.44
- BLFS $27.52
- Average True Range (ATR)
- CNNE 0.42
- BLFS 0.84
- MACD
- CNNE 0.17
- BLFS -0.14
- Stochastic Oscillator
- CNNE 77.41
- BLFS 36.76
About CNNE Cannae Holdings Inc.
Cannae Holdings Inc is a holding company that manages and operates a group of companies and investments. The company's reportable segments are Restaurant Group, Dun & Bradstreet, Alight, BKFC, Corporate and Other. Majority of the company's revenue is generated from its Restaurant Group segment which represents the operations of O'Charley's and Ninety Nine Restaurants.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.